Sagamihara, Japan

Toshio Haruyama

This inventor holds 3 USPTO granted patents. Top assignee: Mitsubishi Chemical Industries Limited. Active years: 1982-1986.


% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1982-1986

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Toshio Haruyama

Introduction

Toshio Haruyama is a notable inventor based in Sagamihara, Japan. He has made significant contributions to the field of chemistry, particularly in the development of novel intermediates for the preparation of corticoids. With a total of 3 patents to his name, Haruyama's work has had a meaningful impact on pharmaceutical advancements.

Latest Patents

Haruyama's latest patents include "17.beta.-ethynylsteroids and process for preparing same." This patent discloses novel intermediates, specifically 17.beta.-ethynylsteroids, which are useful for the preparation of corticoids such as hydrocortisone and prednisolone. Another significant patent is "Acyloxysteroids and process for producing same." This patent also reveals novel intermediates, namely acyloxysteroids, which serve a similar purpose in the preparation of corticoids.

Career Highlights

Toshio Haruyama is currently employed at Mitsubishi Chemical Industries Limited, where he continues to innovate and contribute to the field of chemical research. His work is characterized by a focus on developing processes that enhance the efficiency and effectiveness of pharmaceutical compounds.

Collaborations

Haruyama has collaborated with notable colleagues such as Issei Nitta and Shinya Inoue. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Toshio Haruyama's contributions to the field of chemistry, particularly through his patents, highlight his role as a significant inventor in the pharmaceutical industry. His work continues to influence the development of important medical compounds.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…